Search research articles
Contact Us
Filters
Showing results (871-880 of 1,095) with videos related to
Page
of 110
Sort By:
European Urology
|
March 23, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study
Roberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, et al.
G3 (Bethesda, Md.)
|
November 4, 2022
A chromosome-length genome assembly and annotation of blackberry (Rubus argutus, cv. "Hillquist")
Tomáš Brůna, Rishi Aryal, Olga Dudchenko, et al.
European Journal of Gastroenterology & Hepatology
|
October 24, 2014
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
Maria Buti, Rosa M Morillas, Juan Pérez, et al.
Oncotarget
|
March 31, 2016
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
Daniele Santini, Matteo Santoni, Alessandro Conti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey
Tatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 19, 2026
Real-World Outcomes of Opti-Hep-D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care
Adriana Palom, Ariadna Rando-Segura, Laura Calatayud-Samper, et al.
Journal of Clinical Microbiology
|
October 1, 2020
Amino Acid Substitutions Associated with Treatment Failure for Hepatitis C Virus Infection
María Eugenia Soria, Carlos García-Crespo, Brenda Martínez-González, et al.
Alimentary Pharmacology & Therapeutics
|
October 31, 2023
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
Scott K Fung, Calvin Q Pan, Grace Lai-Hung Wong, et al.
Frontiers in Bioscience (Elite Edition)
|
September 24, 2023
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score
Giulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial
Andrea Ardizzoni, Marcello Tiseo, Luca Boni, et al.
Page
of 110
Search research articles
Search
Showing results (871-880 of 1,095) with videos related to
Sort By:
Page
of 110
European Urology
|
March 23, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study
Roberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, et al.
G3 (Bethesda, Md.)
|
November 4, 2022
A chromosome-length genome assembly and annotation of blackberry (Rubus argutus, cv. "Hillquist")
Tomáš Brůna, Rishi Aryal, Olga Dudchenko, et al.
European Journal of Gastroenterology & Hepatology
|
October 24, 2014
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
Maria Buti, Rosa M Morillas, Juan Pérez, et al.
Oncotarget
|
March 31, 2016
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
Daniele Santini, Matteo Santoni, Alessandro Conti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey
Tatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 19, 2026
Real-World Outcomes of Opti-Hep-D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care
Adriana Palom, Ariadna Rando-Segura, Laura Calatayud-Samper, et al.
Journal of Clinical Microbiology
|
October 1, 2020
Amino Acid Substitutions Associated with Treatment Failure for Hepatitis C Virus Infection
María Eugenia Soria, Carlos García-Crespo, Brenda Martínez-González, et al.
Alimentary Pharmacology & Therapeutics
|
October 31, 2023
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
Scott K Fung, Calvin Q Pan, Grace Lai-Hung Wong, et al.
Frontiers in Bioscience (Elite Edition)
|
September 24, 2023
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score
Giulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial
Andrea Ardizzoni, Marcello Tiseo, Luca Boni, et al.
Page
of 110